Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

Sodium channel NaV1.9 mutations associated with insensitivity to pain dampen neuronal excitability.

Huang J, Vanoye CG, Cutts A, Goldberg YP, Dib-Hajj SD, Cohen CJ, Waxman SG, George AL Jr.

J Clin Invest. 2017 Jun 30;127(7):2805-2814. doi: 10.1172/JCI92373. Epub 2017 May 22.

2.

Association of rare missense variants in the second intracellular loop of NaV1.7 sodium channels with familial autism.

Rubinstein M, Patowary A, Stanaway IB, McCord E, Nesbitt RR, Archer M, Scheuer T, Nickerson D, Raskind WH, Wijsman EM, Bernier R, Catterall WA, Brkanac Z.

Mol Psychiatry. 2018 Feb;23(2):231-239. doi: 10.1038/mp.2016.222. Epub 2016 Dec 13.

3.

MicroRNA-30b regulates expression of the sodium channel Nav1.7 in nerve injury-induced neuropathic pain in the rat.

Shao J, Cao J, Wang J, Ren X, Su S, Li M, Li Z, Zhao Q, Zang W.

Mol Pain. 2016 Oct 19;12. pii: 1744806916671523. Print 2016.

4.

Distal Sensorimotor Neuropathy: Improvements in Diagnosis.

Vas PR, Sharma S, Rayman G.

Rev Diabet Stud. 2015 Spring-Summer;12(1-2):29-47. doi: 10.1900/RDS.2015.12.29. Epub 2015 Aug 10. Review.

5.

Endogenous opioids contribute to insensitivity to pain in humans and mice lacking sodium channel Nav1.7.

Minett MS, Pereira V, Sikandar S, Matsuyama A, Lolignier S, Kanellopoulos AH, Mancini F, Iannetti GD, Bogdanov YD, Santana-Varela S, Millet Q, Baskozos G, MacAllister R, Cox JJ, Zhao J, Wood JN.

Nat Commun. 2015 Dec 4;6:8967. doi: 10.1038/ncomms9967.

6.

SCN9A Variants May be Implicated in Neuropathic Pain Associated With Diabetic Peripheral Neuropathy and Pain Severity.

Li QS, Cheng P, Favis R, Wickenden A, Romano G, Wang H.

Clin J Pain. 2015 Nov;31(11):976-82. doi: 10.1097/AJP.0000000000000205.

7.

Congenital insensitivity to pain: a case report and review of the literature.

Peddareddygari LR, Oberoi K, Grewal RP.

Case Rep Neurol Med. 2014;2014:141953. doi: 10.1155/2014/141953. Epub 2014 Sep 18.

8.

Synthesis and analgesic effects of μ-TRTX-Hhn1b on models of inflammatory and neuropathic pain.

Liu Y, Tang J, Zhang Y, Xun X, Tang D, Peng D, Yi J, Liu Z, Shi X.

Toxins (Basel). 2014 Aug 13;6(8):2363-78. doi: 10.3390/toxins6082363.

9.

The perception and endogenous modulation of pain.

Ossipov MH.

Scientifica (Cairo). 2012;2012:561761. doi: 10.6064/2012/561761. Epub 2012 Dec 25. Review.

10.

Linkage between increased nociception and olfaction via a SCN9A haplotype.

Heimann D, Lötsch J, Hummel T, Doehring A, Oertel BG.

PLoS One. 2013 Jul 10;8(7):e68654. doi: 10.1371/journal.pone.0068654. Print 2013.

11.

Genes and epigenetic processes as prospective pain targets.

Crow M, Denk F, McMahon SB.

Genome Med. 2013 Feb 15;5(2):12. doi: 10.1186/gm416. eCollection 2013. Review.

12.

Pharmacogenomic considerations in opioid analgesia.

Vuilleumier PH, Stamer UM, Landau R.

Pharmgenomics Pers Med. 2012;5:73-87. doi: 10.2147/PGPM.S23422. Epub 2012 Aug 23. Erratum in: Pharmgenomics Pers Med. 2013;6:1.

13.

Tetrodotoxin (TTX) as a therapeutic agent for pain.

Nieto FR, Cobos EJ, Tejada MÁ, Sánchez-Fernández C, González-Cano R, Cendán CM.

Mar Drugs. 2012 Feb;10(2):281-305. doi: 10.3390/md10020281. Epub 2012 Jan 31. Review.

14.

Spider-venom peptides as therapeutics.

Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, King GF.

Toxins (Basel). 2010 Dec;2(12):2851-71. doi: 10.3390/toxins2122851. Epub 2010 Dec 20. Review.

15.

Ototrauma induces sodium channel plasticity in auditory afferent neurons.

Fryatt AG, Mulheran M, Egerton J, Gunthorpe MJ, Grubb BD.

Mol Cell Neurosci. 2011 Sep;48(1):51-61. doi: 10.1016/j.mcn.2011.06.005. Epub 2011 Jun 25.

16.

Nav1.7 is the predominant sodium channel in rodent olfactory sensory neurons.

Ahn HS, Black JA, Zhao P, Tyrrell L, Waxman SG, Dib-Hajj SD.

Mol Pain. 2011 May 10;7:32. doi: 10.1186/1744-8069-7-32.

17.

Loss-of-function mutations in sodium channel Nav1.7 cause anosmia.

Weiss J, Pyrski M, Jacobi E, Bufe B, Willnecker V, Schick B, Zizzari P, Gossage SJ, Greer CA, Leinders-Zufall T, Woods CG, Wood JN, Zufall F.

Nature. 2011 Apr 14;472(7342):186-90. doi: 10.1038/nature09975. Epub 2011 Mar 23.

18.

Pharmacogenetics of new analgesics.

Lötsch J, Geisslinger G.

Br J Pharmacol. 2011 Jun;163(3):447-60. doi: 10.1111/j.1476-5381.2010.01074.x. Review.

19.

Two novel mutations of SCN9A (Nav1.7) are associated with partial congenital insensitivity to pain.

Staud R, Price DD, Janicke D, Andrade E, Hadjipanayis AG, Eaton WT, Kaplan L, Wallace MR.

Eur J Pain. 2011 Mar;15(3):223-30. doi: 10.1016/j.ejpain.2010.07.003. Epub 2010 Aug 7.

20.

Congenital insensitivity to pain: novel SCN9A missense and in-frame deletion mutations.

Cox JJ, Sheynin J, Shorer Z, Reimann F, Nicholas AK, Zubovic L, Baralle M, Wraige E, Manor E, Levy J, Woods CG, Parvari R.

Hum Mutat. 2010 Sep;31(9):E1670-86. doi: 10.1002/humu.21325.

Supplemental Content

Support Center